[Effect of vitamin C administration on gastric colonization by Helicobacter pylori]
Mayra Mayumi Kamiji1, Ricardo Brandt de Oliveira
1Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP. maykamiji@hotmail.com
Background:
The conventional treatment of Helicobacter pylori infection consists on antibiotics, to which a small but significant number of patients are non-responders. Alternative treatments to the infection have been suggested, including the use of antioxidants. There has been such increasing interest upon vitamin C since it was demonstrated vitamin C concentrations in the stomach of infected patients are significant lower compared to healthy subjects. Pharmacological doses of vitamin C have been investigated for eradication of H. pylori, with controversial results.
Aim:
To evaluate the effect of oral administration of vitamin C on H. pylori colonization in the stomach of patients with chronic gastritis and patients with peptic ulcer who had experienced antimicrobial treatment failures.
Material And Methods:
Protocol I: randomized, double-blinded, placebo controlled study, with patients with chronic gastritis, with no previous treatment for eradication. Protocol II: open, uncontrolled study, with patients with peptic ulcer, with at least two previous treatments for eradication. Treatment consisted of 5 g vitamin C for 28 consecutive days. The effect of the treatment was evaluated by 14C-urea breath test concerning eradication rate, radioactivity variation and infection suppression.
Results:
In Protocol I, 38 patients completed the study--21 received vitamin C and 17 received placebo 28 consecutive days. Eradication rates per-protocol analysis with vitamin C were 0, with 95% confidence interval of 0-15%. In Protocol II, eight patients completed treatment. Eradication rate was 0%, with 95% confidence interval of 0-12%. H. pylori load was not decreased.
Conclusion:
Administration of vitamin C, in a 5 g/day dosage during 28 days is neither effective for H. pylori eradication nor quantitatively alters the bacteria load in the stomach of infected patients.
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Microbiota of the Stomach and Small Intestine
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

